Clinical Trial Update: Candin Safety & Efficacy Study for the Treatment of Warts [Phase 2]

View source ↗

Summary

Phase 2 trial update on Candin for warts (HPV) with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Warts

Drugs mentioned

• Candin

Snippet

Sponsor: Nielsen BioSciences, Inc. | Conditions: Warts, Human Papilloma Virus | Phase 2 | Status: COMPLETED | Results posted: 2021-01-11